Headquartered in Beverly, MA Fiscal year ends December NASDAQ: ACLS axcelis.com
Axcelis Technologies, Inc. (Nasdaq: ACLS) designs, manufactures, and provides complete life cycle support for ion implantation systems, one of the most critical and enabling steps in the integrated circuit (IC) manufacturing process. The company has served the semiconductor industry for over 45 years. Its products address key end markets including Memory, Power semiconductors, and General Mature semiconductor applications spanning data center, industrial, and automotive segments. Revenue is derived from product sales (ion implantation systems) and services (customer support and installation). The company has a pending merger agreement with Veeco Instruments, announced on October 1, 2025, expected to close in the second half of 2026. Updated
A fresh Wall Street initiation just sent one of 2026's most explosive small caps through its all-time high, and the analyst behind it called the price target conservative while leaving several major…
For years, owning small-cap stocks felt like watching a neighbor’s party through a window. Large-cap indexes kept climbing, mega-cap technology names absorbed Wall Street’s attention, and smaller domestic companies sat quietly in…
Nervous investors may be wondering if semiconductor stocks are still a good bet this year. Wall Street has not lost faith. Expectations are especially high for Wolfspeed stock.
Axcelis Technologies, Inc. (Nasdaq: ACLS) designs, manufactures, and provides complete life cycle support for ion implantation systems, one of the most critical and enabling steps in the integrated circuit (IC) manufacturing process. The company has served the semiconductor industry for over 45 years.
24/7 Wall St.'s 12-month price target for ACLS is $173.37, rated Buy. The Wall Street consensus target is $161.00. ACLS price prediction →
